Literature DB >> 14284897

[FORMININOGLUTAMIC ACID (FIGLU) EXCRETION DURING THERAPY WITH CYCLOPHOSPHAMIDE].

H BERNDT, I HILLER.   

Abstract

Entities:  

Keywords:  BRONCHIAL NEOPLASMS; CYCLOPHOSPHAMIDE; DRUG THERAPY; FIGLU TEST; GLUTAMATES; SARCOIDOSIS

Mesh：

Substances：

Year:  1965        PMID： 14284897     DOI： 10.1007/bf01485253

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN： 0023-2173


× No keyword cloud information.
  4 in total

1.  ABNORMAL URINARY EXCRETION OF UROCANIC ACID AND FORMIMINOGLUTAMIC ACID IN NEOPLASTIC DISEASE.

Authors:  I W DYMOCK
Journal:  Lancet       Date:  1964-07-18       Impact factor: 79.321

2.  URINARY FORMIMINOGLUTAMIC ACID EXCRETION IN PATIENTS WITH NEOPLASTIC DISEASE.

Authors:  R W CAREY; G P BRENA; M J KRANT
Journal:  Cancer       Date:  1964-06       Impact factor: 6.860

3.  The effect of nitrogen mustard and cyclophosphamide on gastric secretion in man.

Authors:  P BAUME
Journal:  Am J Dig Dis       Date:  1962-10

4.  Simplified method for detecting formiminoglutamic acid in urine as a test of folic-acid deficiency.

Authors:  J P KNOWLES; T A PRANKERD; R G WESTALL
Journal:  Lancet       Date:  1960-08-13       Impact factor: 79.321
  4 in total
  1 in total

1.  [Influence of cytostatic amethopterin chemotherapy on the thiamine supply].

Authors:  H Berndt; I Kutschke
Journal:  Klin Wochenschr       Date:  1967-08-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.